Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy

Table 3

Total donor chimerism on day 100.

Chimerism results at day 100				P value
	FluBu4 with PK	FluBu4 with no PK	BuCy
100% donor	14	13	17	.006
86%–99%	3	12	0
<85%	4	9	6

Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; PK, pharmacokinetics.